<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Alterity Therapeutics Limited

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Alterity Therapeutics Limited

    We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases. Alterity Therapeutics was incorporated in Melbourne, Australia in 1997 as Prana Biotechnology and has offices in Melbourne, Australia, and San Francisco, USA. The Company listed on the Australian Securities Exchange in 2000 and listed on the NASDAQ in 2002. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Geoffrey Kempler
    • FOUNDED
      1997
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Hologic, Inc.

    Hologic, Inc.

    As the leader women’s health, we deliver life-changing and life-saving diagnosti...

    As the leader women’s health, we deliver life...

    Filing Type:    PU
    Arcturus Therapeutics Holdings Inc.

    Arcturus Therapeutics Holdings Inc.

    Arcturus Therapeutics is developing portfolio of RNA therapeutics for treatment of...

    Arcturus Therapeutics is developing portfolio o...

    Filing Type:    PU
    Neopenda, PBC

    Neopenda, PBC

    Neopenda is a medical device startup creating solutions that give patients in low-...

    Neopenda is a medical device startup creating s...

    Amount Raised:    $288,184.00
    Fundraising Status:    EC
    Filing Type:    CF
    Aduro Biotech, Inc.

    Aduro Biotech, Inc.

    Aduro is dedicated to its mission to discover, develop, and commercialize immunoth...

    Aduro is dedicated to its mission to discover, ...

    Filing Type:    PU
    Allena Pharmaceuticals, Inc.

    Allena Pharmaceuticals, Inc.

    Allena’s lead product candidate, reloxaliase, is a first-in-class, oral enzyme t...

    Allena’s lead product candidate, reloxaliase,...

    Filing Type:    PU
    InflaRx N.V.

    InflaRx N.V.

    InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on ap...

    InflaRx (Nasdaq: IFRX) is a clinical-stage biop...

    Filing Type:    PU
    Denali Therapeutics Inc.

    Denali Therapeutics Inc.

    We discover and develop medicines to defeat neurodegeneration. The science is brea...

    We discover and develop medicines to defeat neu...

    Filing Type:    PU
    Prevail Therapeutics Inc.

    Prevail Therapeutics Inc.

    Prevail Therapeutics is applying precision medicine to the development of gene the...

    Prevail Therapeutics is applying precision medi...

    Filing Type:    PU
    Neurotrope, Inc.

    Neurotrope, Inc.

    Neurotrope is a clinical-stage biotech company leveraging Bryostatin-1 and its ana...

    Neurotrope is a clinical-stage biotech company ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.